4baseCare, a lumina accelerator company offering cutting-edge precision oncology solutions using advanced genomics and digital health technology, has launched operations in Dubai by establishing a state-of-the-art genomics laboratory at Dubai Science Park, in collaboration with Innovate Life Sciences. .
4baseCare said the expansion aligns with its strategic plan to strengthen its presence in Southeast Asia and the Middle East.
Founded in 2018 by Hitesh Goswami and Kshitij Rishi, 4baseCare has been a pioneer in launching unique solutions in cancer care to help oncologists match patients with the right targeted therapy based on biomarker identification.
The expansion follows the recent Series A funding round.
The development comes more than two months after he raised $6 million in a Series A funds round led by Yali Capital, with participation from others investors.
The launch event was held on October 17, 2024, with the esteemed presence of Marwan Abdulaziz Janahi, Senior Vice President of Dubai Science Park, and Iqbal Khan, CEO of Fajr Capital, as guests of honour.
Provide genomic testing solutions
4baseCare’s new genomics laboratory will provide cutting-edge genomic testing solutions, including comprehensive cancer gene panels, whole exome sequencing and transcriptome analysis.
These advanced tools will allow oncologists to delve deeper into the genetic makeup of tumors, offering personalized and more effective treatment options.
“Genomics is essential to unlocking life-changing therapies, and 4baseCare’s partnership with Innovate Life Sciences, one of more than 500 industry leaders at Dubai Science Park, is a critical step in realizing its potential,” said Marwan Abdulaziz Janahi, Senior Vice President of Dubai Science Park at TECOM Group.
“As the direction of collaborations such as Innovate Life Sciences with 4baseCare, the Dubai Science Park community is enabling advances in healthcare to benefit patients, in line with the objectives of the Dubai Research and Development Program and the Economic Agenda of Dubai ‘D33’,” Janahi added.
4baseCare CEO highlights the importance of this partnership
Hitesh Goswami, CEO of 4baseCare, said: “Cancer affects us all – our families, our friends, our communities. The global burden of this disease continues to increase and we cannot wait any longer to act. “Through this partnership, we are bringing hope to cancer patients across the Middle East.”
“We are committed to ensuring that advanced, personalized cancer care is accessible to everyone who needs it,” Goswami said.
“Our new partnership at Dubai Science Park is a collaborative effort to manage the economic burden of cancer and expand access to cancer care. The rising costs of cancer control are an undeniable challenge for the ME region. The long-term sustainability of cancer care will require the collaboration of diverse stakeholders. “With this partnership, we are fully committed to helping doctors and patients in the Middle East access the best that precision oncology has to offer,” he added.
4baseCare also introduced SoLiq, a portfolio of solid-liquid NGS tests that combines the best of both worlds (solid and liquid biopsy technologies) to give oncologists a 360° view of tumor biology.
Disclaimer:
The information contained in this post is for general information purposes only. We make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the post for any purpose.
We respect the intellectual property rights of content creators. If you are the owner of any material featured on our website and have concerns about its use, please contact us. We are committed to addressing any copyright issues promptly and will remove any material within 2 days of receiving a request from the rightful owner.